Search results
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks· 1 day agoFree Report) reported better-than-expected results for the first quarter of 2024. Core earnings (excluding one-time charges) of $1.80 per share beat the Zacks Consensus Estimate of $1.73 and ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 4 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Johnson & Johnson Sees Unusually High Options Volume (NYSE:JNJ)
ETF DAILY NEWS· 1 day agoJohnson & Johnson (NYSE:JNJ – Get Free Report) was the target of unusually large options trading activity on Monday. Stock investors bought 45,802 call options on the company. Raymond James ...
Johnson & Johnson (NYSE:JNJ) Position Lowered by Lakeside Advisors INC.
ETF DAILY NEWS· 1 day agoLakeside Advisors INC. trimmed its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities ...
Tyche Wealth Partners LLC Takes Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 1 day agoTyche Wealth Partners LLC bought a new stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission ...
Lindbrook Capital LLC Acquires 358 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 2 days agoLindbrook Capital LLC grew its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 23.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities ...
Zurcher Kantonalbank Zurich Cantonalbank Has $173.91 Million Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 1 day agoZurcher Kantonalbank Zurich Cantonalbank boosted its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 21.5% during the 4th quarter, according to the company in its most recent Form ...
Cantargia Publishes New Data on the CAN10 Antibody, Detailing its Interaction with IL1RAP and...
Digital Journal· 7 days agoThe CAN10 surrogate also inhibited disease development in models of systemic sclerosis, psoriasis, psoriatic arthritis, atherosclerosis and peritonitis.
TD Cowen Lowers Amgen (NASDAQ:AMGN) Price Target to $360.00
ETF DAILY NEWS· 5 days agoAmgen (NASDAQ:AMGN – Get Free Report) had its price target dropped by TD Cowen from $370.00 to $360.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a ...
UBS Group Trims Amgen (NASDAQ:AMGN) Target Price to $284.00
ETF DAILY NEWS· 4 days agoAmgen (NASDAQ:AMGN – Free Report) had its price objective trimmed by UBS Group from $314.00 to $284.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently ...